The European Union needs sooner procedures to provide generic variations of medication with out the consent of patent holders, an EU doc says, in a transfer meant to bypass regular mental rights protections in distinctive circumstances. "The Fee sees the necessity to make sure that efficient methods for issuing obligatory licences are in place, for use as a way of final resort and a security internet, when all different efforts to make IP (mental property) out there have failed," the doc printed on Wednesday stated. The measure, if ever utilized, would successfully enable EU states to provide generic medicine with out the consent of the pharmaceutical firms that developed them and nonetheless personal the mental property rights.